Home/OverT Bio/Christine Baker
CB

Christine Baker

Corporate & Business Development Advisor

OverT Bio

Therapeutic Areas

OverT Bio Pipeline

DrugIndicationPhase
OVT-101Ovarian Cancer & Other Solid TumorsPre-clinical
OVT-201Solid TumorsDiscovery